THU0148 Increase of night qt-interval duration in rheumatoid arthritis patients treated with tofacitinib during 12-month follow-up

IG Kirillova; D Novikova; E Luchikhina; E Markelova; H Udachkina; N Demidova; A Misiyuk; T Popkova; A Volkov; L Denisov; D Karateev

doi:10.1136/annrheumdis-2017-eular.5119

Article info

Poster Presentations

Rheumatoid arthritis - comorbidity and clinical aspects

THU0148 Increase of night qt-interval duration in rheumatoid arthritis patients treated with tofacitinib during 12-month follow-up

Free

Authors

IG Kirillova V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
D Novikova V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
E Luchikhina V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
E Markelova V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
H Udachkina V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
N Demidova V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
A Misiyuk V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
T Popkova V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
A Volkov V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
L Denisov V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles
D Karateev V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation PubMed articles Google scholar articles

Citation

Kirillova I, Novikova D, Luchikhina E, et al

THU0148 Increase of night qt-interval duration in rheumatoid arthritis patients treated with tofacitinib during 12-month follow-up

Annals of the Rheumatic Diseases 2017;76:256-257.

Publication history

First published June 15, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password